News for Fennec Pharmaceuticals Stock (FENC)

ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Fennec Pharmaceuticals Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - FENC

Newsfile Corp • 03/16/22

ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Fennec Pharmaceuticals Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - FENC

PRNewsWire • 03/16/22

ROSEN, A LEADING NATIONAL FIRM, Encourages Fennec Pharmaceuticals Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - FENC

Newsfile Corp • 03/14/22

FENC Investors Have Opportunity to Lead Fennec Pharmaceuticals Inc. Securities Fraud Lawsuit

PRNewsWire • 03/14/22

ROSEN, SKILLED INVESTOR COUNSEL, Encourages Fennec Pharmaceuticals Inc. Investors With Losses Exceeding $100K to Secure Counsel Before Important Deadline in Securities Class Action - FENC

Newsfile Corp • 03/13/22

ROSEN, A LEADING LAW FIRM, Encourages Fennec Pharmaceuticals Inc. Investors With Losses Over $100K to Secure Counsel Before Important Deadline in Securities Class Action - FENC

Newsfile Corp • 03/12/22

ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Fennec Pharmaceuticals Inc. Investors With Losses Over $100K to Secure Counsel Before Important Deadline in Securities Class Action - FENC

Newsfile Corp • 03/09/22

ROSEN, A LEADING LAW FIRM, Encourages Fennec Pharmaceuticals Inc. Investors With Losses to Secure Counsel Before Important Deadline in Securities Class Action - FENC

PRNewsWire • 03/08/22

ROSEN, Global Investor Counsel, Encourages Fennec Pharmaceuticals Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - FENC

Newsfile Corp • 03/08/22

ROSEN, RESPECTED INVESTOR COUNSEL, Encourages Fennec Pharmaceuticals Inc. Investors With Losses to Secure Counsel Before Important Deadline in Securities Class Action - FENC

PRNewsWire • 02/28/22

Fennec Pharmaceuticals Announces Fiscal Year 2021 Financial Results And Provides Business Update

GlobeNewsWire • 02/28/22

ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages Fennec Pharmaceuticals Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - FENC

Newsfile Corp • 02/25/22

ROSEN, Top Ranked Investor Counsel, Encourages Fennec Pharmaceuticals Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - FENC

Newsfile Corp • 02/24/22

Deadline Reminder: Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Fennec Pharmaceuticals Inc. (FENC)

Business Wire • 02/22/22

ROSEN, LEADING TRIAL ATTORNEYS, Encourages Fennec Pharmaceuticals Inc. Investors With Losses to Secure Counsel Before Important Deadline in Securities Class Action - FENC

Newsfile Corp • 02/20/22

ROSEN, SKILLED INVESTOR COUNSEL, Encourages Fennec Pharmaceuticals Inc. Investors With Losses to Secure Counsel Before Important Deadline in Securities Class Action - FENC

PRNewsWire • 02/18/22

Kirby McInerney LLP Investors That a Class Action Lawsuit Has Been Filed on Behalf of Fennec Pharmaceuticals Inc. (FENC) Investors and Encourages Investors to Contact the Firm Before April 11, 2022

Business Wire • 02/18/22

Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Fennec Pharmaceuticals Inc. (FENC)

Business Wire • 02/18/22

FENC Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Notifies Fennec Pharmaceuticals Inc. Investors of Class Action and Encourages Investors to Contact the Firm

Newsfile Corp • 02/17/22

INVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Fennec Pharmaceuticals Inc. (FENC) Investors

Business Wire • 02/16/22

Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces the Filing of a Securities Class Action on Behalf of Fennec Pharmaceuticals Inc. (FENC) Investors

Business Wire • 02/15/22

The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of Fennec Pharmaceuticals Inc. (FENC) Investors

Business Wire • 02/14/22

Shareholder Alert: Robbins LLP Reminds Investors That Fennec Pharmaceuticals Inc. (FENC) is Being Sued for Misleading Shareholders

Business Wire • 02/14/22

FENNEC ALERT: Bragar Eagel & Squire, P.C. Announces That a Class Action Lawsuit Has Been Filed Against Fennec Pharmaceuticals Inc. and Encourages Investors to Contact the Firm

Business Wire • 02/12/22

Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Fennec Pharmaceuticals Inc. (FENC) on Behalf of Investors

Business Wire • 02/11/22